EMN14/54767414MMY3013 (APOLLO) (R/R)

EMN14/54767414MMY3013 (APOLLO) (R/R)

A Phase 3 Study Comparing Pomalidomide and Dexamethasone With or Without Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma (MM) Who Have Received at Least One Prior Line of Therapy With Both Lenalidomide and a Proteasome Inhibitor (APOLLO)


Study Treatments


Inclusion criteria


Exclusion criteria


Participating sites

Link